Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about MERCK & CO., INC.
05:54pMerck Pausing Enrollment for Two Trials of Oral Islatravir
DJ
05:16pMerck Pauses Two Phase 3 Trials Evaluating Islatravir for Pre-Exposure Prophylaxis
MT
05:01pMerck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational,..
BU
02:03pMerck, Thermo Fisher Partner Over Expanding Investigational Antiviral Drug Production F..
MT
11:24aMerck Expands Covid-19 Antiviral Drug Production in Ontario
DJ
10:52aMerck Canada Announces Expansion of Manufacturing for Molnupiravir, an Investigational ..
AQ
04:28aFDA Approves Merck's KEYTRUDA as Adjuvant Treatment for Adult and Pediatric Patients Wi..
AQ
12:34aMerck & Co. Executive Says COVID-19 Pill's Safety Profile Remains 'Very Strong'
MT
12/03FDA Approves Merck's KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Pedi..
BU
12/03Merck in Supply Agreement With Canada for Antiviral Medicine for Covid-19
DJ
12/03Merck Canada Announces Supply Agreement of Up to 1 Million Patient Courses of Molnupira..
AQ
12/03KYODO NEWS DIGEST : Dec. 3, 2021 -3-
AQ
12/03U.S. pharma Merck unit seeks Japan's approval of oral COVID drug
AQ
12/03Merck & Co. Said to Seek Japanese Regulatory Nod for COVID-19 Pill
MT
12/03Merck Applies for Covid Pill Approval in Japan, Nikkei Reports
DJ
More most relevant news
All news about MERCK & CO., INC.
05:54pMerck Pausing Enrollment for Two Trials of Oral Islatravir
DJ
05:16pMerck Pauses Two Phase 3 Trials Evaluating Islatravir for Pre-Exposure Prophylaxis
MT
05:01pMerck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational,..
BU
02:03pMerck, Thermo Fisher Partner Over Expanding Investigational Antiviral Drug Production F..
MT
11:24aMerck Expands Covid-19 Antiviral Drug Production in Ontario
DJ
10:52aMerck Canada Announces Expansion of Manufacturing for Molnupiravir, an Investigational ..
AQ
10:03aIO Biotech Signs Clinical Collaboration Deal to Evaluate its Cancer Drug With Merck's K..
MT
06:46aMarketScreener's World Press Review - December 6, 2021
04:28aFDA Approves Merck's KEYTRUDA as Adjuvant Treatment for Adult and Pediatric Patients Wi..
AQ
12:34aMerck & Co. Executive Says COVID-19 Pill's Safety Profile Remains 'Very Strong'
MT
More news
News in other languages on MERCK & CO., INC.
05:16pMerck interrompt deux essais de phase 3 évaluant l'islatravir pour la prophylaxie pré-e..
02:03pMerck et Thermo Fisher s'associent pour étendre la production d'un médicament antiviral..
10:03aIO Biotech signe un accord de collaboration clinique pour évaluer son médicament contre..
08:39aMERCK : feu vert de la FDA dans le traitement du mélanome
05:43aPLANÈTE BOURSE : La revue de presse du lundi 6 décembre 2021
12:34aMerck & Co. Un cadre supérieur affirme que le profil de sécurité de la pilule COVID-19 ..
12/03Merck & Co schließt Liefervereinbarung mit Kanada für Covid-19-Medikament
12/03MERCK : examen prioritaire de la FDA pour le reblozyl
12/03Le Nikkei 225 gagne 1 % grâce à la demande d'homologation du médicament Covid-19 de Mer..
12/03Merck & Co. Merck chercherait à obtenir l'aval des autorités japonaises pour la pilule ..
More news
Analyst Recommendations on MERCK & CO., INC.
11/30ANALYST RECOMMENDATIONS : Best Buy, Beyond Meat, Booking, Merck, Pfizer...
11/29SVB Leerink Adjusts Merck & Co.'s Price Target to $102 from $105, Keeps Outperform Rati..
MT
11/29Morgan Stanley Adjusts Merck & Co.'s Price Target to $82 from $88, Keeps Equalweight Ra..
MT
11/29ANALYST RECOMMENDATIONS : Asos, Burberry, Greif, Merck, Mirion Technologies....
11/29Citigroup Cuts Merck & Co. to Neutral From Buy, Price Target to $85 From $105
MT
More recommendations
Press releases
05:01pMerck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational,..
BU
10:52aMerck Canada Announces Expansion of Manufacturing for Molnupiravir, an Investigational ..
AQ
04:28aFDA Approves Merck's KEYTRUDA as Adjuvant Treatment for Adult and Pediatric Patients Wi..
AQ
12/03FDA Approves Merck's KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Pedi..
BU
12/03Merck Canada Announces Supply Agreement of Up to 1 Million Patient Courses of Molnupira..
AQ
More press releases
Upcoming event on MERCK & CO., INC.